Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant.
Villa D, Gubbay J, Sutherland DR, Laister R, McGeer A, Cooper C, Fortuno ES 3rd, Xu W, Shi L, Kukreti V, Crump M, Kuruvilla J. Villa D, et al. Among authors: crump m. Leuk Lymphoma. 2013 Jul;54(7):1387-95. doi: 10.3109/10428194.2012.742524. Epub 2013 Jan 8. Leuk Lymphoma. 2013. PMID: 23240909 Clinical Trial.
Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
Tinmouth A, Tannock IF, Crump M, Tomlinson G, Brandwein J, Minden M, Sutton D. Tinmouth A, et al. Among authors: crump m. Transfusion. 2004 Dec;44(12):1711-9. doi: 10.1111/j.0041-1132.2004.04118.x. Transfusion. 2004. PMID: 15584985 Clinical Trial.
A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.
Crump M, Shepherd L, Lin B. Crump M, et al. Clin Lymphoma. 2005 Jun;6(1):56-60. doi: 10.3816/clm.2005.n.030. Clin Lymphoma. 2005. PMID: 15989710 Clinical Trial. No abstract available.
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma.
Kuruvilla J, Nagy T, Pintilie M, Tsang R, Keating A, Crump M. Kuruvilla J, et al. Among authors: crump m. Cancer. 2006 Jan 15;106(2):353-60. doi: 10.1002/cncr.21587. Cancer. 2006. PMID: 16329112 Free article.
452 results